Seppo Ylä-Herttuala is a Professor at A.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences, University of Eastern Finland. He is also the Director of the Biocenter Kuopio, the National Director EU EATRIS-ERIC infrastructure network and the Director of the National Virus Vector Laboratory. He earned his Ph.D. in Medicine at the University of Tampere in 1987. Furthermore, he is a pioneer and international leader in cardiovascular gene therapy. He was the first in the world to apply adenoviral gene transfer to human arteries in 1995. Since then he has developed both gene transfer vectors and production systems and a highly successful research team focusing on angiogenesis, VEGF biology and its clinical applications.
Well done!
